NextGen Healthcare, Inc. Profile Avatar - Palmy Investing

NextGen Healthcare, Inc.

NextGen Healthcare, Inc. provides healthcare technology solutions in the United States. The company offers clinical care solutions, including NextGen Enterprise EHR; financial solutions, such as NextGen Enterprise PM;
Medical - Healthcare Information Services
US, Atlanta [HQ]

Ratios

14 Sheets · Starting from 2023
Margins, Growth Rates In %
Ratio 2010 2011 2012 2013 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Profitability
Gross Margin
62.03 63.92 64.82 58.79 50.49 54.48 54.19 56.22 54.51 53.38 50.50 50.54 50.46 47.64
Profit Margin
16.58 17.43 17.60 9.28 3.53 5.58 1.15 3.58 0.46 4.63 1.39 1.71 0.27 -0.41
Operating Margin
25.95 26.63 27.03 15.01 5.19 7.33 1.49 5.30 0.53 5.98 3.94 3.75 1.87 2.49
EPS Growth
2.41 24.71 21.70 -44.19 -63.89 73.08 -80.00 233.33 -87.30 897.38 -71.05 27.27 -85.71 -300.00
Return on Assets (ROA)
15.60 16.27 17.18 9.64 3.52 5.94 1.07 3.85 0.47 4.60 1.04 1.48 0.26 -0.30
Return on Equity (ROE)
25.69 27.42 25.63 13.91 5.31 9.64 2.10 5.98 0.75 6.52 1.87 2.20 0.38 -0.66
Return on Invested Capital (ROIC)
23.13 23.49 23.55 12.95 4.89 8.39 1.68 6.50 -4.29 6.41 6.47 4.63 0.78 -1.48
Solvency
Equity Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Debt/Assets
6.29 9.69 5.84 5.38 5.99 9.73 23.32 3.39 12.60 6.89 24.78 4.84 3.19 30.66
Debt/Equity
10.36 16.34 8.71 7.76 9.03 15.80 45.94 5.26 20.09 9.77 44.56 7.23 4.73 68.62
Debt/EBITDA
-97.45 -107.30 -113.42 -97.46 -260.21 -300.12 172.07 -29.10 54.04 -59.54 158.97 -60.06 -74.47 332.59
Debt/Capitalization
9.38 14.04 8.02 7.20 8.28 13.64 31.48 5.00 16.73 8.90 30.82 6.74 4.52 40.69
Interest Debt per Share USD
0.34 0.63 0.44 0.40 0.45 0.74 2.06 0.31 1.08 0.61 2.76 0.52 0.32 4.24
Debt Growth
- - - - - - - - - - - - - - -84.71 130.43 -70.27 1,522.20 -82.52 -35.80 1,272.24
Liquidity
Current Ratio
217.42 206.68 241.60 234.06 210.16 180.58 133.27 114.07 105.25 124.66 181.55 114.95 116.98 202.83
Quick Ratio
199.61 188.46 222.37 209.61 187.55 155.66 118.21 96.17 90.59 107.20 161.57 94.71 92.64 177.50
Cash Ratio
83.54 85.35 103.87 83.44 83.26 76.73 19.68 29.27 21.43 25.80 96.36 40.58 33.08 49.83
Operating Cash Flow Ratio
- - - - - - - - - - - - - - - - - - - - - - - - - - - -
Turnover
Inventory Turnover
8,269.18 6,595.03 4,070.61 26,711.55 26,398.44 35,878.46 40,651.35 141,224.05 134,186.11 205,580.83 1,315.36 1,061.00 948.42 4,705.09
Receivables Turnover
264.30 252.81 289.68 310.43 375.10 442.38 388.59 591.99 570.47 506.95 578.47 569.42 553.61 576.46
Payables Turnover
3,315.59 1,906.70 3,336.78 1,649.00 2,791.11 2,227.63 2,027.82 4,831.83 5,733.09 4,541.55 2,541.95 2,420.67 3,237.30 2,844.89
Asset Turnover
94.08 93.31 97.61 103.88 99.91 106.45 92.78 107.69 102.96 99.30 75.02 86.40 95.01 72.89
Coverage
Interest Coverage
- - - - - - -64,579.44 8,582.90 -15,633.04 564.57 855.93 84.89 1,123.63 1,089.00 594.20 743.16 257.83
Asset Coverage
- - - - - - - - - - - - 200 1,600 800 3,000 200 1,200 1,900 200
Cash Flow Coverage (CFGR)
283.21 190.88 298.53 285.73 390.93 184.73 32.96 688.75 117.86 137.43 47.97 315.88 267.42 15.89
EBITDA Coverage
- - - - - - -101,600 14,700 -17,200 3,400 2,300 400 1,300 1,300 1,900 3,500 800
Dividend Coverage
-100 -100 -100 -100 - - - - - - - - - - - - - - - - - - - -
Time Interest Earned (TIE)
100 100 100 100 100 100 100 100 100 100 100 100 100 100
Market Prospects
Dividend Yield
1.95 1.44 1.60 3.81 4.17 4.44 4.64 - - - - - - - - - - - - - -
Earnings Yield
2.75 2.55 2.95 3.92 1.55 2.84 0.61 1.94 0.28 2.26 1.10 0.79 0.12 -0.23
Price/Earnings (P/E)
3,636.57 3,915.92 3,394.56 2,552.28 6,450.36 3,523.12 16,335.11 5,164.77 35,780.49 4,418.25 9,116.41 12,695.49 87,064.69 -43,525.00
Price/Book (P/B)
934.38 1,073.77 870.06 355.13 342.75 339.61 343.04 308.84 267.74 287.86 170.68 279.85 332.97 288.47
Price/Sales (P/S)
602.90 682.71 597.49 236.93 227.45 196.43 187.64 184.86 163.06 204.51 126.53 216.94 236.22 176.85
Price/Cash Flow (P/CF)
3,186.05 3,443.20 3,344.65 1,602.62 971.21 1,163.56 2,265.12 851.88 1,130.61 2,144.04 798.53 1,226.15 2,630.88 2,645.79
End of NXGN's Analysis
CIK: 708818 CUSIP: 65343C102 ISIN: US65343C1027 LEI: - UEI: -
Secondary Listings
NXGN has no secondary listings inside our databases.